BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24191285)

  • 1. Dynamic CCAAT/enhancer binding protein-associated changes of DNA methylation in the angiotensinogen gene.
    Wang F; Demura M; Cheng Y; Zhu A; Karashima S; Yoneda T; Demura Y; Maeda Y; Namiki M; Ono K; Nakamura Y; Sasano H; Akagi T; Yamagishi M; Saijoh K; Takeda Y
    Hypertension; 2014 Feb; 63(2):281-8. PubMed ID: 24191285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA Methylation of the Angiotensinogen Gene,
    Takeda Y; Demura M; Yoneda T; Takeda Y
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic regulation of the angiotensinogen gene by DNA methylation, which is influenced by various stimuli experienced in daily life.
    Demura M; Demura Y; Takeda Y; Saijoh K
    Hypertens Res; 2015 Aug; 38(8):519-27. PubMed ID: 25809578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single-nucleotide polymorphism in human angiotensinogen gene is associated with essential hypertension and affects glucocorticoid induced promoter activity.
    Jain S; Li Y; Patil S; Kumar A
    J Mol Med (Berl); 2005 Feb; 83(2):121-31. PubMed ID: 15630592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nonclassic CCAAT enhancer element binding protein binding site contributes to alpha-methylacyl-CoA racemase expression in prostate cancer.
    Zha S; Isaacs WB
    Mol Cancer Res; 2005 Feb; 3(2):110-8. PubMed ID: 15755877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of human angiotensinogen (AGT) gene transcription by interferon-gamma: involvement of the STAT1-binding motif in the AGT promoter.
    Jain S; Shah M; Li Y; Vinukonda G; Sehgal PB; Kumar A
    Biochim Biophys Acta; 2006 Jul; 1759(7):340-7. PubMed ID: 16949687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic Regulation of Aldosterone Synthase Gene by Sodium and Angiotensin II.
    Takeda Y; Demura M; Wang F; Karashima S; Yoneda T; Kometani M; Hashimoto A; Aono D; Horike SI; Meguro-Horike M; Yamagishi M; Takeda Y
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29739797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cloning and functional analysis of a factor that binds to the proximal promoter of human angiotensinogen.
    Nakajima T; Inoue I; Cheng T; Lalouel JM
    J Hum Genet; 2002; 47(1):7-13. PubMed ID: 11829142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of signal transducers and activators of transcription 1 and -3 in inducible regulation of the human angiotensinogen gene by interleukin-6.
    Sherman CT; Brasier AR
    Mol Endocrinol; 2001 Mar; 15(3):441-57. PubMed ID: 11222745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple CCAAT binding proteins regulate the expression of the angiotensinogen gene.
    Zhao YY; Qasba P; Siddiqui MA; Kumar A
    Cell Mol Biol Res; 1993; 39(8):727-37. PubMed ID: 7951412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic AMP response element-binding protein (CREB) and CAAT/enhancer-binding protein beta (C/EBPbeta) bind chimeric DNA sites with high affinity.
    Flammer JR; Popova KN; Pflum MK
    Biochemistry; 2006 Aug; 45(31):9615-23. PubMed ID: 16878996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of the Xenopus CCAAT-enhancer binding protein beta gene promoter.
    Foka P; Kousteni S; Ramji DP
    Biochem Biophys Res Commun; 2001 Jul; 285(2):430-6. PubMed ID: 11444861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell- and stage-specific chromatin structure across the Complement receptor 2 (CR2/CD21) promoter coincide with CBF1 and C/EBP-beta binding in B cells.
    Cruickshank MN; Fenwick E; Karimi M; Abraham LJ; Ulgiati D
    Mol Immunol; 2009 Aug; 46(13):2613-22. PubMed ID: 19487031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCAAT enhancer binding protein-beta regulates matrix metalloproteinase-1 expression in interleukin-1beta-stimulated A549 lung carcinoma cells.
    Armstrong DA; Phelps LN; Vincenti MP
    Mol Cancer Res; 2009 Sep; 7(9):1517-24. PubMed ID: 19723873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensinogen gene activation by angiotensin II is mediated by the rel A (nuclear factor-kappaB p65) transcription factor: one mechanism for the renin angiotensin system positive feedback loop in hepatocytes.
    Li J; Brasier AR
    Mol Endocrinol; 1996 Mar; 10(3):252-64. PubMed ID: 8833654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic switching of active promoter and enhancer domains regulates Tet1 and Tet2 expression during cell state transitions between pluripotency and differentiation.
    Sohni A; Bartoccetti M; Khoueiry R; Spans L; Vande Velde J; De Troyer L; Pulakanti K; Claessens F; Rao S; Koh KP
    Mol Cell Biol; 2015 Mar; 35(6):1026-42. PubMed ID: 25582196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of CCAAT/enhancer binding protein-beta (C/EBPbeta) in epigenetic regulation of mouse methionine adenosyltransferase 1A gene expression.
    Ikeda R; Nishida T; Watanabe F; Shimizu-Saito K; Asahina K; Horikawa S; Teraoka H
    Int J Biochem Cell Biol; 2008; 40(9):1956-69. PubMed ID: 18346930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensinogen promoter variants influence gene expression in human kidney and visceral adipose tissue.
    Sarzani R; Bordicchia M; Marcucci P; Minardi D; Muzzonigro G; Dessì-Fulgheri P; Rappelli A
    J Hum Hypertens; 2010 Mar; 24(3):213-9. PubMed ID: 19536167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upstream stimulatory factor is required for human angiotensinogen expression and differential regulation by the A-20C polymorphism.
    Dickson ME; Tian X; Liu X; Davis DR; Sigmund CD
    Circ Res; 2008 Oct; 103(9):940-7. PubMed ID: 18802024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lingual antimicrobial peptide and IL-8 expression are oppositely regulated by the antagonistic effects of NF-κB p65 and C/EBPβ in mammary epithelial cells.
    Liu S; Shi X; Bauer I; Günther J; Seyfert HM
    Mol Immunol; 2011 Mar; 48(6-7):895-908. PubMed ID: 21255844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.